Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Oncologist and NHS Commissioner Perspectives on Reirradiation for Recurrent Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

The AI Innerve Algorithm: Automatic Reproducible Reading for Intraepidermal Nerve Fiber Density Analysis, a New Tool for Small-Fiber Neuropathy Diagnosis.

European journal of neurology·2026
Same author

Entropy Spectroscopy of a Bilayer Graphene Quantum Dot.

Physical review letters·2025
Same author

Homozygous DNAJB4 deletion revealing myopathy with acute respiratory failure.

Revue neurologique·2025
Same author

Extratemporal epilepsies mimicking temporal mesial epilepsy.

Epilepsy & behavior : E&B·2025
Same journal

Clinical predictors of overall survival in very elderly patients with spinal osteosarcoma: an analysis of the surveillance, epidemiology, and end results database.

Neuro-Chirurgie·2026
Same journal

Advances in tailored intraparenchymal delivery of regenerative medicine for spinal cord injury: a review of preclinical studies and clinical trials.

Neuro-Chirurgie·2026
Same journal

The renal involvement during lateral lumbar interbody fusion: a radioanatomical study for surgical risk stratification.

Neuro-Chirurgie·2026
Same journal

Chronic inflammatory involvement of the sacral multifidus insertion, predominantly observed after lumbar surgery.

Neuro-Chirurgie·2026
Same journal

Contrast-enhanced ultrasound in brain tumor surgery: clinical applications, intraoperative utility, and safety - A systematic review.

Neuro-Chirurgie·2026
Same journal

Incidence and risk factors of sport-related concussion in amateur handball players: findings from the PRECCOCE study.

Neuro-Chirurgie·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
08:26

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Published on: April 12, 2018

8.6K

[Intramedullary hemangioblastomas].

P David1, M Messerer2, N Aghakhani2

  • 1Service de neurochirurgie, hôpital Bicêtre, AP-HP, 78, rue du General-Leclerc, 94275 Le Kremlin-Bicêtre cedex, France; Centre expert national cancers rares PREDIR, hôpital Bicêtre, AP-HP, 78, rue du General-Leclerc, 94275 Le Kremlin-Bicêtre, France.

Neuro-Chirurgie
|March 2, 2016
PubMed
Summary
This summary is machine-generated.

Surgical management of intramedullary hemangioblastomas, rare spinal tumors often linked to Von Hippel Lindau disease, yields positive outcomes. Complete resection is achievable in most cases, leading to stability or improvement for the majority of patients.

Keywords:
Hémangiobastomes intramédullairesIntramedullary hemangioblastomasMaladie de Von Hippel LindauSpinal cord tumorsTumeurs de la moelle épinièreVon Hippel Lindau

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.7K
Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

9.0K

Related Experiment Videos

Last Updated: Mar 24, 2026

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
08:26

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Published on: April 12, 2018

8.6K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.7K
Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

9.0K

Area of Science:

  • Neurosurgery
  • Oncology
  • Genetics

Background:

  • Intramedullary hemangioblastomas are rare spinal tumors, accounting for 1-5% of all spinal neoplasms.
  • These lesions are frequently associated with Von Hippel Lindau disease, a genetic disorder.
  • Surgical intervention is the primary treatment modality for these tumors.

Purpose of the Study:

  • To review the surgical management experience with intramedullary hemangioblastomas.
  • To analyze clinical presentation, radiological findings, surgical procedures, and outcomes.
  • To evaluate the association with Von Hippel Lindau disease.

Main Methods:

  • Retrospective analysis of 59 patients with intramedullary hemangioblastomas operated between 1993 and 2011.
  • Screening for Von Hippel Lindau disease in all patients.
  • Minimum follow-up of 3 years, recording clinical, radiological, and surgical data.

Main Results:

  • A total of 65 tumors were analyzed in 59 patients (mean age 38 years).
  • Von Hippel Lindau disease was present in 72.5% of patients.
  • Complete resection was achieved in 95% of cases, with 86% experiencing stability and 12% clinical improvement.

Conclusions:

  • Screening for Von Hippel Lindau disease is crucial for all patients with intramedullary hemangioblastomas.
  • Close monitoring is recommended for patients diagnosed with Von Hippel Lindau disease.
  • Surgical removal is strongly advised for tumors causing neurological deficits or showing radiological progression.